Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Cost-effectiveness analysis for the use of serum antiepileptic drug level monitoring in children diagnosed with structural-metabolic epilepsy.

Salih MR, Bahari MB, Shafie AA, Hassali MA, Al-Lela OQ, Abd AY, Ganesan VM.

Epilepsy Res. 2013 Mar;104(1-2):151-7. doi: 10.1016/j.eplepsyres.2012.09.012. Epub 2012 Oct 25.

PMID:
23103061
[PubMed - indexed for MEDLINE]
2.

Medical care costs of newly diagnosed children with structural-metabolic epilepsy: a one year prevalence-based approached.

Salih MR, Bahari MB, Shafie AA, Hassali MA, Al-lela OQ, Abd AY, Ganesan VM.

Seizure. 2012 Dec;21(10):764-9. doi: 10.1016/j.seizure.2012.08.005. Epub 2012 Aug 29.

PMID:
22939458
[PubMed - indexed for MEDLINE]
Free Article
3.

Cost-effectiveness of pediatric epilepsy surgery compared to medical treatment in children with intractable epilepsy.

Widjaja E, Li B, Schinkel CD, Puchalski Ritchie L, Weaver J, Snead OC, Rutka JT, Coyte PC.

Epilepsy Res. 2011 Mar;94(1-2):61-8. doi: 10.1016/j.eplepsyres.2011.01.005.

PMID:
21306874
[PubMed - indexed for MEDLINE]
4.

The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review.

Connock M, Frew E, Evans BW, Bryan S, Cummins C, Fry-Smith A, Li Wan Po A, Sandercock J.

Health Technol Assess. 2006 Mar;10(7):iii, ix-118. Review.

PMID:
16545206
[PubMed - indexed for MEDLINE]
Free Article
5.

Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy.

Blais L, Sheehy O, St-Hilaire JM, Bernier G, Godfroid P, LeLorier JJ.

Pharmacoeconomics. 2005;23(5):493-503. Erratum in: Pharmacoeconomics. 2005;23(9):944. Blais, Lucie [added].

PMID:
15896100
[PubMed - indexed for MEDLINE]
6.

A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy.

Jannuzzi G, Cian P, Fattore C, Gatti G, Bartoli A, Monaco F, Perucca E.

Epilepsia. 2000 Feb;41(2):222-30.

PMID:
10691121
[PubMed - indexed for MEDLINE]
7.

Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.

Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.

Pediatrics. 2006 Aug;118(2):e371-8. Epub 2006 Jul 17.

PMID:
16847080
[PubMed - indexed for MEDLINE]
Free Article
8.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

PMID:
15842952
[PubMed - indexed for MEDLINE]
Free Article
9.

[Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy--preliminary results].

Picot MC, Neveu D, Kahane P, Crespel A, Gélisse P, Hirsch E, Derambure P, Dupont S, Landré E, Chassoux F, Valton L, Vignal JP, Marchal C, Rougier A, Lamy C, Semah F, Biraben A, Arzimanoglou A, Petit J, Thomas P, Dujols P, Ryvlin P.

Rev Neurol (Paris). 2004 Jun;160 Spec No 1:5S354-67. Review. French.

PMID:
15331984
[PubMed - indexed for MEDLINE]
10.

The use of lamotrigine and other antiepileptic drugs in paediatric patients at a Malaysian hospital.

Ab Rahman AF, Ibrahim MI, Ismail HI, Seng TB.

Pharm World Sci. 2005 Oct;27(5):403-6.

PMID:
16341748
[PubMed - indexed for MEDLINE]
11.

Practices associated with serum antiepileptic drug level monitoring at a pediatric neurology clinic: a Malaysian experience.

Salih MR, Bahari MB, Hassali MA, Shafie AA, Al-Lela OQ, Abd AY, Ganesan V.

J Pharm Pract. 2013 Jun;26(3):192-7. doi: 10.1177/0897190012451926. Epub 2012 Jul 13.

PMID:
22797836
[PubMed - indexed for MEDLINE]
12.

Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsy.

Markowitz MA, Mauskopf JA, Halpern MT.

Neurology. 1998 Oct;51(4):1026-33.

PMID:
9781524
[PubMed - indexed for MEDLINE]
13.

Therapeutic monitoring of antiepileptic drugs for epilepsy.

Tomson T, Dahl ML, Kimland E.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002216. Review.

PMID:
17253477
[PubMed - indexed for MEDLINE]
14.

Cost-utility analysis of rufinamide versus topiramate and lamotrigine for the treatment of children with Lennox-Gastaut Syndrome in the United Kingdom.

Verdian L, Yi Y.

Seizure. 2010 Jan;19(1):1-11. doi: 10.1016/j.seizure.2009.10.003. Epub 2009 Nov 25.

PMID:
19942457
[PubMed - indexed for MEDLINE]
Free Article
15.

A cost-effectiveness decision model for antiepileptic drug treatment in newly diagnosed epilepsy patients.

Knoester PD, Deckers CL, Termeer EH, Boendermaker AJ, Kotsopoulos IA, de Krom MC, Keyser T, Renier WO, Hekster YA, Severens HL.

Value Health. 2007 May-Jun;10(3):173-82.

PMID:
17532810
[PubMed - indexed for MEDLINE]
16.

Cost-effectiveness of add-on lamotrigine therapy in clinical practice.

Knoester PD, Boendermaker AJ, Egberts AC, Hekster YA, Keyser A, Severens JL, Renier WO, Deckers CL.

Epilepsy Res. 2005 Dec;67(3):143-51. Epub 2005 Nov 8.

PMID:
16288850
[PubMed - indexed for MEDLINE]
17.

The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK.

Benedict A, Verdian L, Maclaine G.

Pharmacoeconomics. 2010;28(3):185-99. doi: 10.2165/11313640-000000000-00000. Erratum in: Pharmacoeconomics. 2011 Dec 1;29(12):1014.

PMID:
20151724
[PubMed - indexed for MEDLINE]
18.

Direct medical costs of refractory epilepsy incurred by three different treatment modalities: a prospective assessment.

Boon P, D'Havé M, Van Walleghem P, Michielsen G, Vonck K, Caemaert J, De Reuck J.

Epilepsia. 2002 Jan;43(1):96-102.

PMID:
11879393
[PubMed - indexed for MEDLINE]
19.

[Cost-minimisation analysis of the pharmacological treatment of epilepsy in Spain].

Rubio M, Lizán L, Badia X, Escartín-Siquier AE, López-Trigo J, Rufo-Campos M, Echarri E.

Rev Neurol. 2006 Mar 1-15;42(5):257-64. Spanish.

PMID:
16538587
[PubMed - indexed for MEDLINE]
Free Article
20.

A review of the costs of managing childhood epilepsy.

Beghi E, Frigeni B, Beghi M, De Compadri P, Garattini L.

Pharmacoeconomics. 2005;23(1):27-45. Review.

PMID:
15693726
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk